期刊文献+

类风湿关节炎相关抗体测定及其临床实用性的研究 被引量:1

Significance of detection of the autoantibodies in patients with rheumatoid arthritis
原文传递
导出
摘要 目的探讨类风湿关节炎相关抗体测定及临床意义。方法随机选人于本科住院治疗的RA患者500例,应用免疫比浊法检测RF-IgM,酶联免疫吸附法检测HRF-IgG、HRF-IgA及antiCCP抗体,间接免疫荧光染色法检测APF和AKA,分析总结上述抗体及其联合检测在RA诊断中的合理应用。结果(1)500例RA患者血清中自身抗体RF-IgM、anti-CCP、APF、HRF-IgG、AKA、HRFIgA检出的敏感性分别为78.0%、70.8%、51.8%、48.4%、45.O%、20.0%。以RF-IgM检出率最高,其次为anti-CCP。(2)在110例RF-IgM阴性的患者中anti—CCP、APF、AKA、HRF.IgG、HRF.IgA抗体的阳性检出率分别为41.8%、27.3%、22.7%、15.5%、1.8%,尤以anti-CCP的互补作用最好。(3)在146例anti-CCP抗体阴性的患者中RF-IgM、HRF-IgG、APF、AKA、HRF-IgA抗体的阳性检出率分别为56.8%、24.7%、16.4%、8.9%、7.5%。(4)RF-IgM和(或)anti-CCP和(或)APF三种抗体联合和RF-IgM和(或)anti-CCP和(或)HRF-IgG三种抗体联合检出的敏感性最高,分别为88.6%、88.4%,显著优于抗体的单独检测(P〈0.05或P〈0.01),抗体间的联合检测能增加检出的敏感性(P〈0.05或P〈0.01)。结论四种自身抗体在RA中诊断的敏感性以RF-IgM、anti-CCP较为突出且二者的联合检测可提高RA诊断的敏感性。 Objective To explore the sensitivity of antibodies against RF, APF, AKA, anti-CCP in rheumatoid arthritis ( RA ) and analyze the relationship between these autoantibodies in RA. Methods Five hundreds of RA patients were studied. Immunoturbidmetry was used to measure the RF-IgM. The en- zyme-linked immunosorbent assay (ELISA) was used to measure the HRF-IgG, HRF-IgA and anti-CCP. Indirect immunofluorescence was used to measure the APF and AKA. Results The seropositive rates of RF-IgM, anti-CCP, APF, HRF-IgG, AKA and HRF-IgA were 78.0%, 70. 8%, 51.8%, 48.4%, 45.0% and 20. 0% respectively. RF-IgM could not be detected in 110 patients while the seropositive rates of anti-CCP, APF, AKA, HRF-IgG and HRF-IgA were 41.8%, 27. 3%, 22. :/%, 15.5% and 1.8% respectively. Anti-CCP could not be detected in 146 patients while the seropositive rates of RF-IgM, HRF- IgG, APF, AKA and HRF-IgA were 56. 8%, 24. 7%, 16.4%, 8.9% and 7.5% respectively. The combined sensitivities of RF-IgM anti-CCP and APF were higher than others. The seropositive rates were 88.6%. Conclusions RF-IgM and anti-CCP are sensitive antibodies for diagnosis of RA. Combinations RF-IgM with anti-CCP can significantly improve the sensitivity of diagnosis of RA.
出处 《中国医师杂志》 CAS 2011年第4期477-479,483,共4页 Journal of Chinese Physician
关键词 关节炎 类风湿/免疫学 抗体/代谢 免疫球蛋白M/代谢 类风湿因子/代谢 角蛋白质类/代谢 Arthritis, rheumatoid/IM Antibodies/ME Immunoglobulin M/ME Rheumatoid factor/ME Keratins/ME
  • 相关文献

参考文献11

  • 1Arnett FC,Edworthy SM,Bloch DA,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatiod arthritis. Arthritis & Rheumatism, 1988,31 ( 3 ) :315-324.
  • 2Nell VP, Machold KP, Stamm TA, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis ,2005,64 ( 12 ) : 1731-1736.
  • 3Thomas D, Karl E, Eugen F, et al. Rheumatoid factor revisited. Curr. Opin. Rheumatol,2004,16 ( 3 ) : 246 -253.
  • 4Solbritt RD, Ben AWde Jong, Ewa Berglin, et al. Atibodies Against Cyclic Citrullinated Peptide and IgA Rheumatoid Factor Predict the Development of Rheumatiod Arthritis. Arthritis &Rheumatism, 2003,48 ( 10 ) :2741-2749.
  • 5何菁 贾汝琳 等.隐性类风湿因子在类风湿关节炎诊断中的意义[J].中华风湿病杂志,2001,5:24-24.
  • 6Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Atrhritis & Rheumatism, 2000,43 (1) :155- 163.
  • 7Vincent C, Simon M,Sebbag M, et al. hnmunoblotting detection of autoantibodies to human epidermis filaggrin:a new diagnostic test for rheumatoid arthritis. J Rheumatol, 1998,25 ( 2 ) :838-846.
  • 8Menard HA, Lapionte E, Rochdi M,et al. Insights into rheumatiod arthritis derived from the Sa immune system. Arthritis Res, 2000,2(6) :429-432.
  • 9Meyer O, Labarre C, Dougados M, et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis,2003,62 (2) :120-126.
  • 10Vallbracht I, Rieker J, Oppermann M, et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in reheumatoid arthritis. Ann Rheum Dis ,2004,63 (9) : 1079-1084.

共引文献13

同被引文献21

  • 1Brickmann K, Brezinschek RI, Yazdani-Biuki B, et al. Superior specificity of anti-citmllinated peptide antibodies in patients with chronic lymphocytic leukemia and arthritis[J]. Clin Exp Rheuma- tol,2010,28 (6) :888-891.
  • 2Dami6n-Abrego GN, Cabiedes j, Cabral AR. Anti-citrullinated peptide antibodies in lupus patients with or without deforming ar- thropathy[J]. Lupus, 2008, 17(4) : 300-304.
  • 3Aggarwal R, Liao K, Nair R, et al. Anti-citrullinated peptide an- tibody assays and their role in the diagnosis of rheumatoid arthritis [J]. Arthritis Rheum, 2009, 61 ( 11 ) : 1472-1483.
  • 4Arkema EV, Goldstein BL, Robinson W, et al. Anti-citrullinated peptide autoaatibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis : a nested case-control study [J]. Arthritis Res Ther, 2013, 15(5) : R159.
  • 5Goldman K, Gertel S, Amital H. Anti-citrullinated peptide anti- bodies is more than an accurate tool for diagnosis of rheumatoid ar- thritis[J]. Isr Med Assoc J, 2013, 15(9) : 516-519.
  • 6Ruiz-Esquide V, G6mara M J, Peinado VI, et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheuma- toid arthritis. A differential effect of chronic obstructive pulmonary disease? [J]. Clin Rheumatol, 2012, 31(7): 1047-1050.
  • 7Saeki Y, Kudo-Tanaka E, Ohshima S, et al. Baseline anti-citrul- linated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA) [ J ]. Rheumatol Int, 2013, 33(2) : 451-456.
  • 8Steiner G, Shovman O, Skriner K, et al. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP com- plex of spliceosome by idiotypic manipulation with anti-RA33 an- tibody preparation in mice [ J ]. Clin Exp Rheumatol, 2002, 20 (4) : 517-524.
  • 9Tomoum HY, Mostafa GA, E1-Shahat EM. Autoantibody to het- erogeneous nuclear ribonucleoprotein-A2 ( RA33 ) in juvenile idi- opathic arthritis: clinical significance[J]. Pediatr Int, 2009, 51 (2) : 188-192.
  • 10Hoffmann MH, Tuncel J, Skrilmr K, et al. The rheumatoid ar- thritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis [ J]. J Immunol, 2007, 179 ( 11 ) : 7568-7576.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部